^
CANCER:

Pituitary Gland Carcinoma

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
MGMT underexpression
Pituitary Gland Carcinoma
temozolomide
Sensitive
:
C3
TMB-L + PD-L1 underexpression
Pituitary Gland Carcinoma
nivolumab + ipilimumab
Sensitive
:
C3
SDHB mutation
Pituitary Gland Carcinoma
temozolomide
Sensitive
:
C4
MSH2 mutation + MSH6 mutation
Pituitary Gland Carcinoma
pembrolizumab
Sensitive
:
C4
STK11 mutation
Pituitary Gland Carcinoma
temozolomide + capecitabine
Resistant
:
C4
STK11 mutation
Pituitary Gland Carcinoma
everolimus
Sensitive
:
C4
ATRX mutation + TP53 mutation + PTEN mutation
Pituitary Gland Carcinoma
temozolomide
Sensitive
:
C4
TMB-H
Pituitary Gland Carcinoma
nivolumab + ipilimumab
Resistant
:
C4
TMB-H
Pituitary Gland Carcinoma
temozolomide
Resistant
:
C4
MSH2 deletion + MSH6 deletion
Pituitary Gland Carcinoma
temozolomide
Resistant
:
C4